Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,738 | -36,206 | -19,670 | -4,172 | -37,230 |
| Depreciation Amortization | 2,459 | 1,850 | 1,242 | 625 | 2,311 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 164 |
| Accounts receivable | -1,813 | N/A | N/A | N/A | 5,343 |
| Accounts payable and accrued liabilities | 7,049 | N/A | N/A | N/A | -4,354 |
| Other Working Capital | 30,525 | 33,789 | 33,733 | -9,724 | -16,377 |
| Other Operating Activity | -142 | 3,851 | 2,463 | 1,133 | 4,247 |
| Operating Cash Flow | $-7,660 | $3,284 | $17,768 | $-12,138 | $-45,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -949 | -607 | -257 | -28 | -2,726 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -41,499 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 83,437 |
| Investing Cash Flow | $-949 | $-607 | $-257 | $-28 | $39,212 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 59,127 | 54,226 | 32,310 | 9,693 | 10,115 |
| Financing Cash Flow | $59,127 | $54,226 | $32,310 | $9,693 | $10,115 |
| Exchange Rate Effect | -3,190 | -2,287 | -1,160 | -1,128 | 4,745 |
| Beginning Cash Position | 70,436 | 70,436 | 70,436 | 70,436 | 62,260 |
| End Cash Position | 117,764 | 125,052 | 119,097 | 66,835 | 70,436 |
| Net Cash Flow | $47,328 | $54,616 | $48,661 | $-3,601 | $8,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,660 | 3,284 | 17,768 | -12,138 | -45,896 |
| Capital Expenditure | -949 | -607 | -257 | -28 | -2,726 |
| Free Cash Flow | -8,609 | 2,677 | 17,511 | -12,166 | -48,622 |